Retapamulin clinical trials
Also written Altabax.
How each study uses retapamulin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 12 Apr 2007 · ALTABAX · NDA 022055 (FDA, Drugs@FDA)
- European Union
- 24 May 2007 · Altargo · EMEA/H/C/000757 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
9 studies that test it; most in 2009 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2012 | 2 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 8
Gary Goldenberg (1) · NYU Langone Health (1) · University of California, Irvine (1) · GlaxoSmithKline (1) · Derm Research, PLLC (1) · The University of Texas Health Science Center, Houston (1) · Ochsner Health System (1) · Bay Pines VA Healthcare System (1)
Studies
Open first, then newest update. How each study uses retapamulin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Treatment of Staphylococcus Aureus Colonization in Hand EczemaCompletedNot applicableGary GoldenbergNCT01591785Written as Retapamulin 1% ointment
- Retapamulin as a Decolonizing Agent for MRSACompletedPhase 3NYU Langone HealthNCT03304873Written as Retapamulin
- Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal ColonizationWithdrawnPhase 4Ochsner Health SystemNCT00856089Written as Retapamulin
- Retapamulin for Reducing MRSA Nasal CarriageCompletedPhase 4University of California, IrvineNCT01461668Written as Retapamulin
- Treatment of Patients Colonized With Methicillin-Resistant Staphylococcus Aureus Prior to Bone and Joint SurgeryWithdrawnPhase 2Bay Pines VA Healthcare SystemNCT00903279Written as Altabax (retapamulin)
- Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus AureusCompletedPhase 2GlaxoSmithKlineNCT00539994Written as retapamulin
- Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic DermatitisCompletedPhase 4Derm Research, PLLCNCT01064947Written as Retapamulin 1%
- Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue InfectionCompletedPhase 4The University of Texas Health Science Center, HoustonNCT01126268Written as Retapamulin (Altabax)
- Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapyWithdrawnPhase 4St. Luke's-Roosevelt Hospital CenterNCT00871208Written as Altabax (R)
As the comparator · 1 — what is tested is compared with retapamulin
Codes
What other systems call retapamulin · ClinicalTrials.gg INT004885
- MeSH (NLM) C508887retapamulinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 4MG6O8991RRETAPAMULINConfirmed FDA, NLM, Wikidata
- RxNorm 642274Confirmed FDA, Wikidata
- Wikidata Q7316645retapamulinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61924RetapamulinOne source FDA
- DrugBank DB01256One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C508887 | retapamulin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 4MG6O8991R | RETAPAMULIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 642274 | — | Confirmed FDA, Wikidata |
| Wikidata | Q7316645 | retapamulin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61924 | Retapamulin | One source FDA |
| DrugBank | DB01256 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.